
Charming Medical, Diageo, UP Fintech, Regencell Bioscience, and Baiya International Group are the five Chinese stocks to watch today, according to MarketBeat’s stock screener tool. “Chinese stocks” refers to shares of companies that are based in China or that conduct a significant portion of their business in China, and whose shares may trade on Chinese or international stock exchanges. For investors, the term often includes mainland-listed companies as well as Chinese firms listed abroad, such as in the U.S. or Hong Kong, and is commonly used to describe a broad group of China-related equity investments. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Charming Medical (MCTA)
We are a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. We offer a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance.
Diageo (DEO)
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.
Read Our Latest Research Report on DEO
UP Fintech (TIGR)
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.
Read Our Latest Research Report on TIGR
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Read Our Latest Research Report on RGC
Baiya International Group (BIYA)
We, Baiya International Group Inc. (“Baiya”), are an offshore holding company incorporated in the Cayman Islands. We are not a Chinese operating company, but an offshore holding company incorporated in the Cayman Islands. As a holding company, we have no material operations and conduct all of our operations in China through the VIE, Shenzhen Gongwuyuan Network Technology Co., Ltd.
Read Our Latest Research Report on BIYA
Further Reading
- MarketBeat’s Top Five Stocks to Own in May 2026
- AAPL: Forget the iPhone—Services Will Drive the Next Phase of Growth
- Ackman and Berkshire Are Betting Against Each Other on AI
- The $132 Billion Infrastructure Pivot You Might Have Missed
- Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings
- Rewiring AI: NextEra Energy Sparks a Mega Merger
